Pulmonary Sarcoidosis Activation following Neoadjuvant Pembrolizumab plus Chemotherapy Combination Therapy in a Patient with Non-Small Cell Lung Cancer: A Case Report

BACKGROUND: Pembrolizumab is a humanized monoclonal antibody which serves to enhance the antitumor immune response by targeting programmed cell death 1 receptor. The use of pembrolizumab plus carboplatin/pemetrexed combination therapy results in improvement in overall survival and progression-free s...

Descripción completa

Detalles Bibliográficos
Autores principales: Fakhri, Ghina, Akel, Reem, Salem, Ziad, Tawil, Ayman, Tfayli, Arafat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836160/
https://www.ncbi.nlm.nih.gov/pubmed/29515398
http://dx.doi.org/10.1159/000484596

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836160/
https://www.ncbi.nlm.nih.gov/pubmed/29515398
http://dx.doi.org/10.1159/000484596

Ejemplares similares